OAM
ADMA icon

OP Asset Management’s ADMA Biologics ADMA Stock Holding History

OP Asset Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-271,192
Closed -$4.95M – 786
2025
Q4 		$4.95M Buy
271,192
+157,602
+139% +$2.66M 0.06% 240
2025
Q3 		$1.67M Buy
113,590
+33,848
+42% +$580K 0.02% 494
2025
Q2 		$1.45M Buy
79,742
+58,279
+272% +$1.19M 0.02% 531
2025
Q1 		$426K Buy
+21,463
New +$371K 0.01% 699

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

OP Asset Management's ADMA Position: Q1 2026 in Review

OP Asset Management sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 271,192 shares — an estimated $4.95M sold.

OP Asset Management first reported a position in ADMA in Q1 2025 and held it in 4 quarters. The position peaked at $4.95M in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • OP Asset Management reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • OP Asset Management sold 271,192 ADMA Biologics shares in Q1 2026, an estimated $4.95M.
  • OP Asset Management first reported a position in ADMA Biologics in Q1 2025 and held it in 4 quarters.
  • OP Asset Management's ADMA Biologics position peaked at $4.95M in Q4 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on OP Asset Management's 13F filing for Q1 2026, filed 9 Apr 2026.